In tropical Singapore, influenza occurs all year-round. This study of influenza-confirmed hospitalized pediatric patients compared clinical characteristics and complications by age-group and differences between influenza A and B.
cases were defined as upper respiratory tract manifestations and influenza-unrelated illness, for example, urinary tract infection (UTI).
High dependency (HD) is a unit that caters for more severely ill patients requiring closer monitoring or non-invasive ventilation without needing ICU admission. Obesity was defined as BMI > 25 kg/m 2 .
Immunosuppression was defined as non-malignancy related immunosuppressive therapy, for example, steroids, biological modifying agents. Pneumonia was defined as fever and cough with chest Xray (CXR) changes of lobar/broncho-pneumonia or focal infiltrates.
Positive bacterial tests were either culture-positive from any site or positive mycoplasma PCR or serology (particle agglutination IgG antibody ≥320 single titer). C-reactive protein was the result on admission. Criteria for treating influenza with oseltamivir were as follows: age <2 years or any high-risk factor for complicated disease within 3 days of onset, or severe disease based on clinician assessment independent of duration since onset.
Statistical analysis was performed using the spss 19.0 statistical software program. Student's t test or one-way ANOVA were used to compare continuous data; chi-square test or Fisher's exact test was used to compare categorical data, using P < .05 as statistical significance. This study was approved by the internal review board for waiver of consent.
Incidence of influenza hospitalization was derived using 56.8% market share for admissions in children and calculated as per 100 000 population based on the number of children in that agegroup (information from MOH and Singapore government statistics).
| RE SULTS
There were a total of 1272 influenza-positive patients admitted with a median age of 37 months (IQR 13-76 months); males constituted 56.5%. Majority were positive for influenza by IF (96.5%) compared to PCR (3.5%). The median length of stay (LOS) was 3 days (IQR 2-4 days). C-reactive protein and chest X-ray were performed in 28.8% and 31.1% of patients, respectively.
Figure 1 shows the burden of influenza hospitalizations by
year, age-groups, and subtypes/lineages (excluding unknown subtypes/lineages). Incidence of hospitalized influenza was highest for <6 months, followed by 6-month to <5-year-age-group and lowest in ≥10-year-age-group. Figure 2 shows the monthly incidence of Fifty-six (4.4%) cases were admitted ICU or HD. Table 3 lists the type of complications. Neurologic complications were the most frequent (46.5%) followed by pulmonary (37.5%) and other (16.0%).
The seven complicated cases with confirmed bacterial coinfection were as follows: two pneumococcal bacteremia, two S pyogenes bacteremia, one each for P aeuginosa pneumonia, Mycoplasma pneumonia, and campylobacter gastroenteritis (admitted for febrile seizure).
Overall, oseltamivir (OSV) usage was 2.0%, especially higher in complicated cases (3.6% vs 1.3%, P = .007), ICU/HD admissions (19.6% vs 1.2%, P < .001), underlying comorbidity (4.5% vs 1.3%, P = .002), cardiac disease (10.7% vs 1.6%, P < .001), and malignancy (30% vs 1.7%, P = .001). In contrast, any antibiotic usage was 28.4%.
Comparing patients with other complications against neurologic and pulmonary complications, they had the highest ICU/HD admissions (34.6% vs 12.6%, 10.7%, respectively, P < .001), highest influenza B rates (36.5% vs 10.6%, 18.9%, respectively, P < .001) and oldest age (mean 90.3 vs 50.6, 42.1 months respectively, P < .001).
Pulmonary complications compared to neurologic and other complications had highest ILI rates (91.8% vs 68.2%, 76.9% respectively, P < .001), longest cough duration (6.5 days vs 3.2, 3.7 days, respectively, P = .010). LOS was not significantly different between the type of complications.
The mortality rate in our cohort was 0.2%. The three deaths were as follows: Acute necrotizing encephalitis, invasive pneumococcal disease, decompensated liver failure in a biliary atresia patient post-Kasai procedure. One cerebral palsy patient with no prior seizures developed sequelae of epilepsy.
| D ISCUSS I ON
The main findings from our study were that the highest burden of influenza hospitalizations was in the <6-month-age-group, followed by the 6-month to <5-year-age-group. Majority (75.2%) of pediatric inpatients had no comorbidity and 25.6% had complications: neurologic 11.9%, pulmonary 9.6%, and other 4.1%. The 6-month to <5-year-age-group suffered the highest complication rate (30.6%).
Influenza A patients were younger, had higher seizure rates and complications compared to influenza B.
In our study, the highest hospitalization rate occurred in the <6-month-age-group. This is similar to Hong Kong but different from temperate countries where the highest rates occurred in the 6-to 23-month-age-group. [10] [11] [12] Patients who were ≤6 weeks or <3 months old were likely admitted for neonatal or infantile pyrexia workup, this can explain the high UTI rates and antibiotic usage in this age-group. At the average rate of 881.68 per 10 5 population for <6 months old, it is higher than temperate countries. 3, 13 This could be due to all year-round influenza with bimodal peaks, similar to Malaysia. 14 Studies have shown that maternal influenza vaccination can prevent influenza in infants; therefore, pregnant women should receive influenza vaccination to protect their infants. 15, 16 The age-group 6 month to <5 years was the largest cohort (54%) with the second-highest hospitalization rate and the highest complication rate (30.6%) especially neurologic, similar to another study. 17 In other studies, the age-group 6-35 months or the lowest agegroups had the highest incidence of complications. 11, 18, 19 However, the ≥10-year-old-age-group had the highest other complications, ICU/high-dependency admissions, and influenza B Victoria rates. This is unlike other studies which had higher ICU admissions in the youngest age-groups <12 months. 20 In addition, the ≥10-year-old-age-group had the highest LOS likely from underlying comorbidity especially ≥2 comorbidities. One previous study showed that children ≥10 years old with influenza B had the greatest odds of ICU admission if previously healthy. 21 This age-group also had the highest influenza B Victoria rates, implying that they should Abbreviation: SD, standard deviation. especially pneumonia and asthma exacerbation. 11, 16 20, 24 In two published studies, encephalitis, encephalopathy, and febrile seizures constituted 0.6%-4.4% of influenza admissions, whereas these constituted 10.3% of our admissions. 16, 20 In a study of influenza vaccine uptake, only 51% and 46% of physicians recognized epilepsy and intellectual disability as high-risk conditions. 25 Physicians should routinely offer influenza vaccination to patients with a prior seizure disorder, neurologic conditions or developmental delay. 26, 27 In our cohort, influenza A comprised 76.9% and had higher complication rates especially neurologic. Influenza B contributed to 23.1% of all admissions in 2013-2014; this is similar to the 19.3% rate for Singapore in 2007-2012. 26 The older age-groups ≥5 years old had higher proportions of influenza B compared to the younger age-groups. This is similar to previous publications which showed that those aged ≥5 years were more likely to have influenza B but different from Hong Kong where the 2-to 4-year-age-group had the highest influenza B hospitalization rates. 10, 21, 27 In 2013-2014, the quadrivalent influenza vaccine was not yet available; the trivalent vaccine would not have covered 5.7% of all strains and up to 10.8% of strains in those ≥10 years. Comparing the two subtypes of influenza A, H3N2 had higher rates of febrile seizures, bacterial pneumonia and lower rates of diarrhea compared to H1N1 pdm2009 (P = .008, .03, .02, respectively). There was no difference in clinical characteristics or severity between the two influenza B lineages, similar to a study from Guangzhou, China. 28 In terms of seasonality, influenza A peaks were mainly driven by H3N2 which were more intense and earlier except in mid-2014, when H1N1 pdm09 and influenza B peaked in June. This is similar to the H3N2 patterns in Shenzhen and Hong Kong in 2012-2013. 29 The predominant lineage for influenza B was Yamagata in both years, similar to that of Malaysia. 30 One limitation of our study was that IF was the main mode of testing, which could lead to an underestimate of the true incidence of influenza hospitalization as PCR is a more sensitive method of testing. However, more severe cases could have been included in this study due to the higher viral burden in respiratory secretions detectable by IF rather than PCR. Obesity was likely under-reported as only 55% of patients had their height taken, thereby leading to an omission of BMI used to determine obesity status. Another limitation was the lack of information of prior influenza vaccination; however, uptake for influenza vaccination in children has generally been poor. Although influenza vaccination is recommended for children under 5 years of age or those with underlying high-risk factors, it is not in the national immunization schedule for children and therefore not routinely offered. As this was a hospital-based study, the observations may have been confounded by the admitting threshold with younger aged children more likely to be admitted. Prior influenza infections would not have been detected as influenza serological testing was not available. It is possible that older children may have had partial immunity to influenza A, not develop severe influenza A and instead be hospitalized for influenza B.
TA B L E 3 Type of complications by Influenza subtype/lineage

| CON CLUS IONS
Infants <6 months had the highest hospitalization rates for influenza. The 6-month to <5-year-age-group had the highest complication rate especially neurologic. Influenza A patients were younger, had higher seizure rates and complications compared to influenza B.
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